At a glance
ClinicalIndex Comparison RecordN/ACompleted· 299 enrolled
Drug / intervention
Stent implantationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Stenting of the Superficial Femoral (SFA) and Proximal Popliteal Arteries (PPA) With the Boston Scientific INNOVA Self-Expanding Bare Metal Stent System
In Brief
A clinical study evaluating Stent implantation for Atherosclerosis of Native Arteries of the Extremities, Unspecified. Completed, enrolled 299 participants across 49 sites in 7 countries.
Detailed Summary
The primary objective of this clinical study is to determine whether the Innova Stent System shows acceptable performance in long-term (12-month) safety rates and vessel patency when treating femoropopliteal lesions.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesAustria, Belgium, Canada, Germany, Japan, United Kingdom, United States
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 2011
Enrollment StartApr 2011
Primary CompletionJul 2014
Study CompletionSep 2016
TodayJul 2026
First PostedFeb 10, 2011
Enrollment StartApr 1, 2011
Primary CompletionJul 1, 2014
Study CompletionSep 1, 2016
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 15.4 years ago
Interventions
Stent implantationdevice
Stent implantation during the index procedure.